Our objective is to develop, and make freely available to the community (through R packages), net survival methods that are adapted for analyzing such data. We will then apply these new statistical methods to answer three epidemiological questions using rich data.
Net survival
Evaluer les pistes possibles et la faisabilité de celles déjà identifiées pour construire, des tables d’EdV à l’échelle infranationale, par sexe, période (idéalement par année), âge en année, comorbidité et PSE, reproductibles en routine et adaptée pour l’estimation de la survie nette en cancérologie.
The major aim of this project is to estimate the net survival at 1, 3 and 5 years after a diagnosis of AML in an international level to identify any geographical distribution of survival.
The second objective is to evaluate the impact of various characteristics on survival or on excess mortality by geographical areas: i) the comorbidity at diagnosis using the Charlson Index, ii) the socio-economic level based on the European Deprivation Index and iii) the therapeutic management of AML.